Chorionic Gonadotropin (Recombinant)
Name: Chorionic Gonadotropin (Recombinant)
- Chorionic Gonadotropin Recombinant drug
- Chorionic Gonadotropin Recombinant names
- Chorionic Gonadotropin Recombinant side effects
- Chorionic Gonadotropin Recombinant and side effects
- Chorionic Gonadotropin Recombinant injection
How do I store and/or throw out Chorionic Gonadotropin?
- Store in the original container at room temperature or in a refrigerator. If stored at room temperature, throw away any part not used after 30 days.
- Protect from light.
- Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.
- Check with your pharmacist about how to throw out unused drugs.
Dosage Forms
Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Injectable, Subcutaneous:
Ovidrel: 250 mcg/0.5 mL (0.5 mL)
Brand Names U.S.
- Ovidrel
Dosing Renal Impairment
Safety and efficacy have not been established.
Test Interactions
May interfere with interpretation of pregnancy tests; may cross-react with radioimmunoassay of luteinizing hormone and other gonadotropins
Patient Education
• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)
• Patient may experience injection site irritation. Have patient report immediately to prescriber signs of severe cerebrovascular disease (change in strength on one side is greater than the other, difficulty speaking or thinking, change in balance, or vision changes), signs of DVT (edema, warmth, numbness, change in color, or pain in the extremities), breast pain, angina, vomiting blood, or signs of ovarian hyperstimulation syndrome (severe abdominal pain or bloating; severe nausea, vomiting, or diarrhea; excessive weight gain; shortness of breath; or change in amount of urine passed) (HCAHPS).
• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for healthcare professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience and judgment in diagnosing, treating and advising patients.